Ivana Horvat, Margareta Radić Antolic, Renata Zadro, Dubravka Sertić, Boris Labar
Original papers, Volume 20, February, Issue 1
KEYWORDS: chronic myeloid leukemia; imatinib mesylate resistance; T315I mutation
Copyright (©) 2010 - 2024 Croatian Society of Medical Biochemistry and Laboratory Medicine. Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License
